Loomis, Sayles & Company’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.5M | Buy |
|
|||||
|
2025
Q2 | $25.6M | Sell |
|
|||||
|
2025
Q1 | $27.3M | Sell |
|
|||||
|
2024
Q4 | $24.6M | Sell |
|
|||||
|
2024
Q3 | $27.6M | Buy |
|
|||||
|
2024
Q2 | $16.6M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $22.2M | Buy |
|
|||||
|
2020
Q4 | $26.3M | Buy |
|
|||||
|
2020
Q3 | $19.3M | Sell |
|
|||||
|
2020
Q2 | $18.7M | Buy |
|
|||||
|
2020
Q1 | $13.1M | Sell |
|
|||||
|
2019
Q4 | $16.4M | Sell |
|
|||||
|
2019
Q3 | $12.2M | Buy |
|
|||||
|
2019
Q2 | $11.7M | Sell |
|
|||||
|
2019
Q1 | $12.6M | Sell |
|
|||||
|
2018
Q4 | $6.75M | Buy |
|
|||||
|
2018
Q3 | $6.24M | Buy |
|